Rais, R., Hoover, R., Wozniak, K., Rudek, M. A., Tsukamoto, T., Alt, J., . . . Slusher, B. S. (2012). Reversible Disulfide Formation of the Glutamate Carboxypeptidase II Inhibitor E2072 Results in Prolonged Systemic Exposures In Vivo. The American Society for Pharmacology and Experimental Therapeutics.
Chicago Style CitationRais, Rana, Randall Hoover, Krystyna Wozniak, Michelle A. Rudek, Takashi Tsukamoto, Jesse Alt, Camilo Rojas, i Barbara S. Slusher. Reversible Disulfide Formation of the Glutamate Carboxypeptidase II Inhibitor E2072 Results in Prolonged Systemic Exposures In Vivo. The American Society for Pharmacology and Experimental Therapeutics, 2012.
Cita MLARais, Rana, et al. Reversible Disulfide Formation of the Glutamate Carboxypeptidase II Inhibitor E2072 Results in Prolonged Systemic Exposures In Vivo. The American Society for Pharmacology and Experimental Therapeutics, 2012.